Examination of the bone marrow includes assessment of hematopoietic tissue cellularity, with an estimate of the relative proportion for each lineage
The cellularity varies with location of biopsy.
(1) The vertebral body is about 10% more cellular than iliac crest.
(2) The sternum can show variable cellularity relative to the iliac crest.
(3) The rib tends to have a lower cellularity than the iliac crest.
Cellularity of hematopoietic tissue as percent of marrow space:
(1) Normally most nucleated cells are hematopoietic
(2) Infiltration by lymphocytes, plasma cells, tumor cells, etc. can reduce relative percent of hematopoietic cellularity
Cellularity:
(1) decreases with age
(2) This is a combined effect of decreased hematopoietic tissue and a reduction in bone.
(3) Adipose tissue fills the nonhematopoietic marrow cavity.
Reference range for hematopoietic cellularity from iliac crest
Age in Years |
Upper Limit |
Mean |
Lower Limit |
0 - < 10 |
95.1% |
78.8% |
59.0% |
10 - < 20 |
86.6% |
64.3% |
41.5% |
20 - < 30 |
83.7% |
58.0% |
32.0% |
30 - < 40 |
81.3% |
47.6% |
30.3% |
40 - < 50 |
75.1% |
48.2% |
16.3% |
50 - < 60 |
73.6% |
46.3% |
19.7% |
60 - < 70 |
65.7% |
45.7% |
16.3% |
70 - < 80 |
47.1% |
28.9% |
11.3% |
Interpretation:
• Cellularity may be considerable affected by technical factors.
• Cellularity less than 20% tends to indicate hypoplasia, except in elderly.
• Cellularity more than 80% tends to indicate hyperplasia, except in patients under 20 years of age.
• A cellularity of 25-75% is usually normal cellularity for patients 20-70 years of age.
Myeloid-to-Erythroid Ratio
myeloid-to-erythroid ratio =
= (cells in myeloid series) / (erythroblasts)
Interpretation:
• normal ratio: 1.2:1 to 5:1
• An increased ratio is seen in granulocytic hyperplasia (leukocytosis, myeloproliferative disorders) or depressed erythropoiesis.
• A decreased ratio seen in depressed leukopoiesis or erythroid hyperplasia.
Megakaryocytes
In bone marrow smears of good cellularity, normally 1-3 megakaryocytes are seen per 100x (10x objective, 10x ocular) field.
Specialty: Hematology Oncology, Clinical Laboratory